iBio Inc (IBIO)

[piecesofeight]

The early bird might get the worm, but the second rat gets the cheese. iBio may not want to rush in and is waiting to see longer term effects of the vaccine as animal and long term studies were never done in the quick trials after development. This is why FDA's New Drug Applications take years to approve. This trial study was not even an Abbreviated New Drug Application. It was "Wham-Bam', out the door and roll up the sleeve. If the mRNA starts showing up serious adverse effects in the longer term, as it may trigger dormant maladies, lawsuits will be flying faster than the spread of COVID itself. Larger companies may be able to withstand the tsunami of liability suits, but smaller caps like iBio would be sunk at the first ripples. I will take my personal stand and be the second rat like iBio may be playing.